Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001683168-26-001026
Filing Date
2026-02-13
Accepted
2026-02-13 17:00:08
Documents
1
Period of Report
2026-02-11

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 5033
  Complete submission text file 0001683168-26-001026.txt   6514
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Issuer) CIK: 0001759186 (see all company filings)

EIN.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6199 Finance Services
(CF Office: 09 Crypto Assets)

Mailing Address 105 BRADFORD RD., SUITE 420 WEXFORD PA 15090
Business Address
Cochran Christopher P. (Reporting) CIK: 0001951916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39669 | Film No.: 26634248